Stereotaxis, Inc. (STXS) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Stereotaxis, Inc. (STXS) Bundle
Explore Stereotaxis, Inc. (STXS) financial prospects with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to calculate the intrinsic value of Stereotaxis, Inc. (STXS) and enhance your investment strategy.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.9 | 26.6 | 35.0 | 28.1 | 26.8 | 26.7 | 26.7 | 26.6 | 26.5 | 26.5 |
| Revenue Growth, % | 0 | -7.86 | 31.51 | -19.63 | -4.89 | -0.21758 | -0.21758 | -0.21758 | -0.21758 | -0.21758 |
| EBITDA | -4.7 | -6.6 | -12.8 | -18.3 | -21.2 | -11.9 | -11.8 | -11.8 | -11.8 | -11.8 |
| EBITDA, % | -16.28 | -24.74 | -36.5 | -65.18 | -79.35 | -44.41 | -44.41 | -44.41 | -44.41 | -44.41 |
| Depreciation | .1 | .1 | .1 | .5 | .6 | .3 | .3 | .3 | .3 | .3 |
| Depreciation, % | 0.42465 | 0.47394 | 0.30169 | 1.89 | 2.22 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 |
| EBIT | -4.8 | -6.7 | -12.9 | -18.9 | -21.8 | -12.1 | -12.1 | -12.1 | -12.1 | -12.0 |
| EBIT, % | -16.7 | -25.21 | -36.8 | -67.07 | -81.58 | -45.47 | -45.47 | -45.47 | -45.47 | -45.47 |
| Total Cash | 30.2 | 43.9 | 38.7 | 28.4 | 19.8 | 25.3 | 25.3 | 25.2 | 25.2 | 25.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.3 | 3.5 | 5.4 | 5.1 | 3.8 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 |
| Account Receivables, % | 18.44 | 13.2 | 15.44 | 18.08 | 14.28 | 15.89 | 15.89 | 15.89 | 15.89 | 15.89 |
| Inventories | 1.8 | 3.3 | 4.4 | 7.9 | 8.4 | 4.9 | 4.8 | 4.8 | 4.8 | 4.8 |
| Inventories, % | 6.39 | 12.37 | 12.66 | 27.98 | 31.47 | 18.18 | 18.18 | 18.18 | 18.18 | 18.18 |
| Accounts Payable | 2.1 | 1.6 | 4.2 | 3.3 | 3.2 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 |
| Accounts Payable, % | 7.26 | 6.04 | 11.96 | 11.62 | 11.92 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 |
| Capital Expenditure | .0 | -.1 | -1.4 | -2.4 | -.4 | -.8 | -.8 | -.8 | -.8 | -.8 |
| Capital Expenditure, % | -0.10202 | -0.26623 | -3.99 | -8.45 | -1.37 | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -4.5 | -6.5 | -10.1 | -19.8 | -21.8 | -11.4 | -11.3 | -11.3 | -11.3 | -11.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -9.4 | -6.6 | -11.9 | -25.7 | -21.0 | -9.3 | -11.8 | -11.8 | -11.8 | -11.7 |
| WACC, % | 11.55 | 11.56 | 11.53 | 11.56 | 11.56 | 11.55 | 11.55 | 11.55 | 11.55 | 11.55 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -40.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -12 | |||||||||
| Terminal Value | -125 | |||||||||
| Present Terminal Value | -72 | |||||||||
| Enterprise Value | -113 | |||||||||
| Net Debt | -14 | |||||||||
| Equity Value | -99 | |||||||||
| Diluted Shares Outstanding, MM | 81 | |||||||||
| Equity Value Per Share | -1.22 |
What You Will Get
- Real Stereotaxis Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Stereotaxis’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Stereotaxis, Inc. (STXS).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to Stereotaxis, Inc. (STXS).
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Stereotaxis, Inc. (STXS) projections.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for Stereotaxis, Inc. (STXS).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of Stereotaxis, Inc. (STXS).
How It Works
- 1. Download the Template: Obtain and open the Excel file containing Stereotaxis, Inc.'s preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results in Real-Time: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
- 5. Present with Assurance: Share professional valuation insights to guide your strategic decisions.
Why Choose This Calculator for Stereotaxis, Inc. (STXS)?
- Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for Stereotaxis, Inc. (STXS).
- Customizable Inputs: Modify yellow-highlighted cells to explore different scenarios for Stereotaxis, Inc. (STXS).
- Detailed Insights: Automatically computes Stereotaxis, Inc. (STXS)'s intrinsic value and Net Present Value.
- Preloaded Data: Includes historical and forecasted data for Stereotaxis, Inc. (STXS) to provide precise starting points.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Stereotaxis, Inc. (STXS).
Who Should Use Stereotaxis, Inc. (STXS)?
- Healthcare Professionals: Enhance patient care with advanced robotic solutions for cardiac procedures.
- Medical Researchers: Utilize cutting-edge technology to conduct innovative studies in electrophysiology.
- Hospital Administrators: Streamline operational efficiency by integrating state-of-the-art systems into existing workflows.
- Investors: Assess growth potential and market trends with comprehensive data on the medical robotics sector.
- Students and Educators: Explore the intersection of technology and medicine through hands-on learning experiences.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Stereotaxis, Inc. (STXS).
- Real-World Data: Stereotaxis's historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into Stereotaxis, Inc. (STXS).
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results specific to Stereotaxis, Inc. (STXS).